NL-OMON41226已完成不适用
A pilot intervention study for the use of VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (pre)malignant Esophageal Lesions - VICE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Identified high grade dysplasia (HGD) or intramucosal adenocarcinoma (EAC; T1) and therefore candidate for endoscopic therapy using EMR.
- •- Mentally competent person, age 18 years or older
- •- Written informed consent.
- •- Adequate potential for follow-up.
排除标准
- •- Medical or psychiatric conditions that compromise the patient*s ability to give informed consent.
- •- Submucosal and invasive EAC ; EAC with TNM-classification other than T1
- •- Concurrent uncontrolled medical conditions or medical conditions which disqualify for an EMR procedure.
- •- Previously preformed therapeutic endoscopic procedures.
- •- Pregnancy or breast feeding.
研究者
相似试验
已完成
不适用
Clinical study in new protocol of anti-VEGF agents for macular edema with retinal vein occlusion and in relation between the protocol and cytokinesRetinal Vein OcclusionJPRN-UMIN000030311Tokyo medical university100
尚未招募
不适用
Evaluation of the responsiveness of anti-VEGF treatment in DMEdiabetic retinopathy (DR)NL-OMON29053GSMS70
已完成
2 期
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the UrotheliumMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerSquamous Cell Carcinoma of the BladderStage III Bladder CancerStage III Urethral CancerStage IV Bladder CancerTransitional Cell Carcinoma of the BladderUrethral Cancer Associated With Invasive Bladder CancerAdenocarcinoma of the BladderDistal Urethral CancerProximal Urethral CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerNCT00407485National Cancer Institute (NCI)22
进行中（未招募）
1 期
A Phase II Randomized Study to Compare Anti-VEGF Agents in the Treatment of Diabetic Macular Edema (CADME) - A Study to Compare Anti-VEGF Agents in the Treatment of DME (CADME)Diabetic Macular Edema (DME)MedDRA version: 15.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853EUCTR2012-005486-13-GBThe National Eye Institute60
已完成
不适用
Validation of Uptake of a VEGF-targeted Optical Fluorescent Imaging Tracer in Surgical Specimens of Breast Cancer and Application of Pre- and Intra-operative Human Molecular Fluorescence Imaging Techniques. A multicenter feasibility study10006291Breast cancerNL-OMON39185niversitair Medisch Centrum Groningen20